Inventors scoop European awards

June 14, 2012
Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize.

Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize here Thursday.

In the research category French scientist Gilles Gosselin, and his co-inventors Jean-Louis Imbach, also of France, and the late US professor Martin L. Bryant won the prize for developing "a highly effective anti-viral drug against hepatitis B".

The new drug shows less cross-resistance with other medications and can thus be used as a first line of treatment, the (EPO) said.

One hundred times more infectious than the that causes AIDS, (HBV) is a particularly persistent disease that chronically affects 350 million people worldwide, despite the availability of vaccines.

Some two billion people have been infected worldwide with HBV.

The EPO's Inventor Award in the category Industry went to Danish scientists Jan Toepholm, Soeren Westermann and Svend Vitting Andersen for developing a tailor-made hearing aid after becoming aware of the drawbacks of traditional hearing-aid design.

In the category Non-European countries the winners were Australians John O' Sullivan, Graham Daniels, Terence Percival, Diethelm Ostry and John Deane, of the Commonwealth Scientific and Industrial Research Organisation, for developing a wireless LAN (local area network) for transfer.

The winner of the European Inventor Award 2012 in the category Lifetime Achievement, German Professor Josef Bille of Heidelberg University, was rewarded for developing a device for .

Bille has filed almost 100 patents in the field of ophthalmology and is a pioneer in the area of laser eye correction.

The Munich-based European Patent Office launched the award in 2006.

Explore further: Patent fight in India centers on AIDS drug

Related Stories

European office withdraws Nexium patent

December 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

EU gives green light for while-you-wait hepatitis B test

May 18, 2010

An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accurate results while-you-wait, ...

Google signs deal to translate European patents

November 30, 2010

(AP) -- Google announced an agreement Tuesday to use its technology to translate patents into 29 European languages, a deal officials hope will smooth the way toward a simplified European patent system after years of infighting.

Recommended for you

Biologists trace how human innovation impacts tool evolution

November 24, 2015

Many animals exhibit learned behaviors, but humans are unique in their capacity to build on existing knowledge to make new innovations. Understanding the patterns of how new generations of tools emerged in prehistoric societies, ...

How experienced buyers can mitigate economic bubbles

November 19, 2015

(—Over the last decade, many people got a tough primer on the effects of economic bubbles, as the bursting of the 2007-2008 housing bubble sent shockwaves through most of the major world economies. But property ...

First Londoners were multi-ethnic mix: museum

November 23, 2015

A DNA analysis of four ancient Roman skeletons found in London shows the first inhabitants of the city were a multi-ethnic mix similar to contemporary Londoners, the Museum of London said on Monday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.